Board approved audited standalone and consolidated FY26 results with revenue of ₹10,421.18 crore and net profit of ₹2,037.56 crore.
Approved additional investment of up to ₹500 crore in wholly-owned subsidiary Mankind Medicare for capacity expansion.
Re-appointed Satish Sharma as Whole-Time Director and M.K. Kulshrestha as Cost Auditor, accepted CIO Pramod Gokhale's resignation.
Executive directors waived commission for FY26 to strengthen cash position for business expansion.